Sichuan Huiyu Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from EDQM.
One of their notable products is IRON SUCROSE, with a corresponding US DMF Number 41482.
Remarkably, this DMF maintains an Active status since its submission on May 15, 2025, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 30, 2025, and payment made on May 07, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II